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Introduction:
Chronic Obstructive Pulmonary Disease (COPD) is a global problem. According to World Bank reports it accounts for 29 million disability-adjusted life-years (DALYS) and 1 million years of life are lost per annum around the world. 1 Many studies have shown COPD prevalence to be around 10 to 15% in smokers. 1 A US based study has showed 4 in 5 patients with COPD are current or former smokers. 2 Literature on COPD screening for smokers in primary care remains controversial. But there is increasing evidence to show that spirometric screening and frequency determination of people with moderate or severe COPD in smokers can significantly improves rates of smoking cessation as compared to rates of cessation in the otherwise general population. 3 Our literature review clearly suggests weakness of epidemiological data in our country. Thus we planned to determine the frequency of COPD in smokers using spirometry as a standard technique.
Methodology:
We conducted a cross sectional study in department of Medicine Civil Hospital Hyderabad from April 2006 to September 2006 in smokers presenting to tertiary care center. The sample size of the study was 100 patients selected through non probability purposive sampling. The inclusion criteria were all males who are current smokers of age >30 years with smoking history of more than seven pack years, giving informed consent were included. Whereas factory workers, those living near the factories and exposed to chemicals like exposures to coal mine dust, cotton dust, silica and grain dust were excluded in the study. Patients of ischemic heart disease, having myocardial infarction in the last one month or having chest pain at rest or on exertion were also excluded from the study. Finally patients with co-morbidities like diabetes and TB., debilitating diseases, very old age (>60 years), previously diagnosed as COPD, taking treatment for COPD were also excluded from the sample.
The main outcome variable of the study was presence of COPD. The effect modifiers were controlled by strict exclusion criteria. The close-ended questionnaire along with proper training of the co-researchers minimizes interviewer bias.
All the selected patients were interviewed by co researcher. COPD was confirmed by spirometry performed by trained technician of at least five years experience. A study diagnosis of COPD was defined as airway obstruction as measured by FEV1/FVC <0.70 measured by trained technician.
The severity of COPD was also diagnosed using Global Initiative for Chronic Obstructive Pulmonary disease (GOLD) by a trained technician in front of coresearcher. The classification cutoffs were mild FEV1/ FVC<0.70 (FEV1 > 80% predicted), moderate FEV1/ FVC < 0.70 (50% < FEV1 < 80% predicted), severe FEV1/FVC < 0.70 (30% > FEV1 < 50% predicted) and very severe FEV1/FVC < 0.70 (FEV1 < 30% predicted or FEV1 < 50% predicted plus chronic respiratory failure)
The data was entered and analyzed in SPSS 12. The quantitative variables include age, age of starting smoking, number of cigarettes smoked per day, expressed as means and S.D. The qualitative variables include sex, occupation, presenting symptoms (cough, sputum and dyspnoea), COPD along with its severity classification (mild, moderate, severe and very severe obstruction), were expressed as percentages. No analytical test was applied.
Results:
The mean age of the clients was 39.77±6.30 years. There were 4 (4%) businessmen, 3 (3%) teachers, 7(7%) drivers, 14 (14%) farmers, 48 (48%) laborers and 24 (24%) shopkeepers (Table-I 
Discussion:
The concept of upstream and downstream approaches to public health interventions were first popularized by John McKinlay. 4 Downstream interventions are focused primarily at the individual level towards tertiary prevention with an aim to change adverse health behaviours. 5, 6 Whereas upstream interventions are targeted at group level and includes efforts at primary level that help in decreasing risk exposure and keeping healthy people healthy. In general upstream interventions are passive interventions, requiring least amount of effort and hence more effective in longer terms. 5, 6 Currently COPD is the 12th leading cause of disability worldwide expected to be fifth by 2020. 1 Globally, smoking is a major cause of COPD and symptoms typically present in mid to later life. 7 Smoking is a major risk factor of COPD and increases with aging due to changes in pulmonary function. 8 A study conducted by Trofor has showed that smoking cessation as mandatory and beneficial in COPD. 9 The results of this study showed higher frequency of COPD in smokers (39%). Further 19 (19%) smokers had mild obstruction, 12 (12%) smokers had moderate obstruction and 8 (8%) smokers had severe obstruction.
There are many studies that have shown high prevalence of COPD in smokers. 2, 3, 10 A study showed 34.9% of people diagnosed with COPD were smokers compared with 22.4% of those without. 11 In a study by Gingter COPD prevalence in smokers was 6.9%. 12 A study conducted in Turkey showed 6.9% of the participants (general population) were found to have COPD with the prevalence of COPD was 18.1% in current smokers. 13 A study in Japan showed overall, 22.5% of patients were current smokers. 14 A study by Pelkonen showed approximately one-quarter of smokers can be affected by clinically significant chronic obstructive pulmonary disease. 9 A study was conducted in Israel that showed COPD prevalence of about 22% in smokers. 15 A study in China showed the smoking rate among COPD patients was significantly higher than that among the controls. 16 A study by Godoy showed that about 57 (36.1%) smokers met the criteria for COPD out of 158 smokers. 10 A study in China showed the overall prevalence of COPD (in the general population) was 8.2%. 17 A study conducted by Tatsumi also showed 15 % of chronic smokers may develop COPD. 18 Our study has also showed a higher prevalence COPD of around 39% in smokers. But few studies have also shown a very low prevalence of COPD in smokers. 1, 12 Our study only included male patients the justification was studies have shown COPD to be more frequently occurred in males than females mostly due to predominance of smoking in males. 19, 20 Another study has showed the presence of COPD was significantly lower among women compared to men. 21 A study in Israel has showed that there was no correlation between pack-years smoking and development of COPD, but there was a relative correlation of pack-years smoking and severity of COPD, particularly in the older group. 15 Our study also showed decrease in FEV1/FVC (severe COPD) with increase in pack years (see Table-III) Study by Plywaczewski has showed that majority of examined subjects presented with COPD symptoms of cough (62.7%), expectoration (68.8%) and dyspnoea (50.2%). 22 Similarly study by Bednarek has showed one third of examined declared morning cough (36.9%) or sputum production (34.8%), or both symptoms (26.7%). 23 The main limitation of the study was a hospital based study not true representative of smokers in general community. But then it would be more advisable and feasible to perform screening in those smokers approaching at a tertiary center. So our results can be used in developing screening strategies to all smokers presenting to tertiary hospitals. The other limitation was, we were unable to control the effect of atmospheric pollution in developing COPD in our target population of smokers. But as our main objective was to provide rationale for screening by determining frequency of COPD in smokers and not association. Thus it does not affect our study objective and outcomes.
Conclusion:
The higher prevalence of COPD in smokers clearly showed the effectiveness and a rationale to conduct screening in the most target group (smokers). But father studies with larger and more multi centric settings involving health economic models should be conducted in order to develop national recommended guidelines in future.
